Tag: Pharmaceutical Distribution

Gilead Sciences and Eisai Agreed on Distribution and Co-Promotion of Filgotinib

Gilead Sciences, Inc. and Eisai Co., Ltd. announced that Gilead Sciences K.K. (Tokyo, Japan) and Eisai have entered into an agreement for the distribution and co-promotion of filgotinib, an investigat...

IceCure Medical in Exclusive Distribution Agreement with Global Medical Company

IceCure Medical has announced an exclusive distribution agreement with global medical company, Terumo Corporation. The new agreement will accelerate the commercialization of its ProSense™ cryoablation...

Alvogen and Covis Pharma Announced Distribution Agreement for commercialization of Alvesco®

Alvogen and Covis Pharma have entered into an exclusive partnership and distribution agreement for the commercialization of Alvesco® (ciclesonide), a leading medicine for the treatment of persistent a...

Can-Fite BioPharma Signed Agreement with Kyongbo Pharm to Distribute Piclidenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it has signed a distribution a...

Lannett in Supply and Distribution Agreement for Levothyroxine Tablets

Lannett announced it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, a wholly owned subsidiary of privately held Ne...

Collaboration of Latvian and Chinese Companies

Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, announced they have entered into a collaboration agreement. Under the agreement...

First Company for medical Cannabis pursue licences around Europe

The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal...

Neovii & Mundipharma entered into licensing agreement

Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Gr...

Fujifilm signed a distribution agreement with R-Pharm

FUJIFILM Corporation signed a distribution agreement with a major Russian pharmaceutical company JSC “R-Pharm” for the distribution of Fujifilm's medical devices in Russia.

EAEU rules of Good Distribution Practice became effective on April 27

EAEU rules of Good Distribution Practice (GDP) were adopted by the Decision of the Council of the Eurasian Economic Commission (EEC) No. 80 of November 3, 2016, while their entry into force was postponed for 18 months.

Ibnsina Pharma will distribute Novo Nordisk products in Egypt

ibnsina pharma egypt
Ibnsina Pharma, Egypt’s fastest-growing and second-largest pharmaceutical distributor, has signed two contracts with Novo Nordiskto distribute over 20 stock-keeping units of its products in Egypt.

Tilray set up a strategic alliance with a leading Canadian pharma company

medicinal cannabis
Tilray, a licensed producer of medical cannabis, signed a binding letter of intent to be the collaborator of a major pharma company to accelerate innovation and increase availability of high quality medical cannabis products.

Blockchain technology has a special potential to confront counterfeit drugs

DHL released a report in cooperation with Accenture on blockchain technology’s potential. The report includes findings on a working prototype which tracks pharmaceuticals from the point of origin to the consumer.

R-Pharm Kazakhstan receives a GDP compliance certificate

In February 2018, the division of R-Pharm Group in Kazakhstan received a certificate of compliance with the Good Distribution Practice (GDP) from the Ministry of Health of the Republic of Kazakhstan. ...

Almac Group opens a custom built cold store facility in Northern Ireland

Almac Group announced the completion of a $27.5 million investment in its cold chain management capabilities with the opening of a custom built cold store facility in Northern Ireland.

Mundipharma will distribute Grünenthal’s analgesic in China

Grünenthal and Mundipharma announced today that they have entered into a License and Distribution Agreement. Under its terms, Mundipharma will market and distribute Grünenthal’s Tramal® in China